DekaBank Deutsche Girozentrale
ODT

DekaBank Deutsche Girozentrale’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,000
Closed -$42K – 1518
2021
Q3 		$42K Hold
14,000
– – ﹤0.01% 1337
2021
Q2 		$49K Hold
14,000
– – ﹤0.01% 1347
2021
Q1 		$44K Hold
14,000
– – ﹤0.01% 1308
2020
Q4 		$248K Buy
+14,000
New +$216K ﹤0.01% 1147

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ODT Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2021, closing a stake of 14,000 shares — an estimated $42K sold.

DekaBank Deutsche Girozentrale first reported a position in ODT in Q4 2020 and held it in 4 quarters. The position peaked at $248K in Q4 2020. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 14,000 Odonate Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $42K.
  • DekaBank Deutsche Girozentrale first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Odonate Therapeutics, Inc. Common Stock position peaked at $248K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.